Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Extended amygdala corticotropin-releasing hormone neurons regulate sexually dimorphic changes in pair bond formation following social defeat in prairie voles (Microtus ochrogaster)
    Published on 2025-02-11
    1 year ago
  • A molecular mechanism mediating clozapine-enhanced sensorimotor gating
    Published on 2025-02-10
    1 year ago
  • Absence of TAAR1 function increases methamphetamine-induced excitability of dorsal raphe serotonin neurons and drives binge-level methamphetamine intake
    Published on 2025-02-10
    1 year ago
  • Brain and cardiovascular responses to acute stress in remitted and recurrent late-life depression
    Published on 2025-02-05
    1 year ago
  • N-acetylcysteine for youth cannabis use disorder: randomized controlled trial main findings
    Published on 2025-02-04
    1 year ago
  • Correction: Neuropsychopharmacology Volume 50 Issue 2
    Published on 2025-01-30
    1 year ago
  • Childhood family environment and μ-opioid receptor availability in vivo in adulthood
    Published on 2025-01-30
    1 year ago
« Previous 1 … 54 55 56 57 58 … 143 Next »
Journal of Psychopharmacology
  • Acute administration of alprazolam, alcohol and their combination on cognitive performance and mood: A randomised, double-blind, placebo-controlled study
    Published on 2023-09-19
    3 years ago
  • Predicting clozapine dose required to achieve a therapeutic plasma concentration – A comparison of a population algorithm and three algorithms based on gene variant models
    Published on 2023-09-12
    3 years ago
  • Psilocybin history, action and reaction: A narrative clinical review
    Published on 2023-08-31
    3 years ago
  • Fluoxetine rescues the depressive-like behaviour induced by reserpine and the altered emotional behaviour induced by nicotine withdrawal in zebrafish: Involvement of tyrosine hydroxylase
    Published on 2023-08-18
    3 years ago
  • Hippocampal and parahippocampal volume and function predict antidepressant response in patients with major depression: A multimodal neuroimaging study
    Published on 2023-08-17
    3 years ago
  • The risk of chronic psychedelic and MDMA microdosing for valvular heart disease
    Published on 2023-08-12
    3 years ago
  • Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study
    Published on 2023-08-04
    3 years ago
« Previous 1 … 54 55 56 57 58 … 145 Next »
European Neuropsychopharmacology
  • Unlocking the enigma: Metabolic risks of typical antipsychotics and their link to COVID-19 mortality
    Published on 2023-10-20
    3 years ago
  • Digital behavioural signatures reveal trans-diagnostic clusters of Schizophrenia and Alzheimer’s disease patients
    Published on 2023-10-20
    3 years ago
  • Pharmacological anti-inflammatory treatment in children and adolescents with depressive symptoms: A systematic-review and meta-analysis
    Published on 2023-10-20
    3 years ago
  • Methodological concerns in psychedelic research: The issues of nonequivalent psychological support and generalizability
    Published on 2023-10-20
    3 years ago
  • Lamotrigine efficacy, safety, and tolerability for women of childbearing age with bipolar I disorder: Meta-analysis from four randomized, placebo-controlled maintenance studies
    Published on 2023-09-28
    3 years ago
  • Acute effects of mifepristone on emotional processing related brain activity: A functional MRI study
    Published on 2023-09-23
    3 years ago
  • Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort
    Published on 2023-09-22
    3 years ago
« Previous 1 … 54 55 56 57 58 … 166 Next »

   Pharma Pub